Nanjing, China, September 2025 — WixBio’s Overseas Business and Technical Departments recently hosted a face-to-face technical exchange meeting in Nanjing with representatives from UNIVET, a partner company from Kazakhstan. The discussions focused on critical technical aspects, including testing methodologies for poultry vaccines, epidemiological compatibility of vaccine strain subtypes, and adaptability to regional conditions.
The meeting aimed to optimize the performance of WixBio’s vaccine products in the Central Asian market, ensuring consistent and effective immune protection across diverse climatic and farming environments. WixBio’s technical team provided a detailed overview of the company’s processes and quality control standards for vaccine antigen preparation, potency testing, specific pathogen-free (SPF) chicken embryo virus titration, and hemagglutination inhibition (HI) antibody monitoring. Additionally, they outlined the company’s approach to strain selection and updates based on country-specific epidemiological data.
Given the recent prevalence of 조류인플루엔자 (H9N2), Newcastle disease (G-7 strain), 그리고 전염성 기관지염 in Kazakhstan, both parties thoroughly evaluated the compatibility of existing vaccine combinations. They also reached a preliminary agreement on the future development of customized multivalent vaccines. WixBio highlighted its robust customization capabilities, enabling rapid adjustments to vaccine formulations to deliver tailored disease prevention strategies, aligning with a “one country, one strategy; one region, one solution” approach.
UNIVET representatives commended WixBio’s technical expertise and responsiveness, stating, “This in-depth exchange has strengthened our confidence in a long-term partnership with WixBio. Their products have demonstrated outstanding immunogenicity and stability in Kazakhstan, earning widespread approval from local farmers and regulatory authorities.”
이번 난징 회의는 기술 협력을 강화했을 뿐만 아니라 WixBio가 중앙아시아에서 입지를 확대할 수 있는 탄탄한 기반을 마련했습니다. WixBio는 앞선 연구개발 역량과 글로벌 서비스 인프라를 바탕으로 제품 맞춤화, 기술 지원, 애프터서비스를 아우르는 종합적인 동물 건강 솔루션을 전 세계 고객에게 제공하기 위해 계속 노력하겠습니다.
